Literature DB >> 21666870

MicroRNAs in mouse models of lymphoid malignancies.

Nicola Zanesi1, Yuri Pekarsky, Francesco Trapasso, George Calin, Carlo M Croce.   

Abstract

The discovery of microRNAs (miRNAs) has revealed a new layer of gene expression regulation that affects many normal and pathologic biological systems. Among the malignancies affected by the dysregulation of miRNAs there are cancers of lymphoid origin, in which miRNAs are thought to have tumor suppressive or tumor promoting activities, depending on the nature of their specific targets. In the last 4-5 years, the experimental field that provided the deepest insights into the in vivo biology of miRNAs is that of mouse modeling in which transgenic and knockout animals mimic, respectively, over-expression or down-regulation of specific miRNAs involved in human leukemia/lymphoma. This review discusses recent advances in our understanding of lymphoid malignancies based on the natural and engineered mouse models of three different miRNAs, miR-15a/16-1 cluster, miR-155, and miR-17-92 cluster.

Entities:  

Year:  2010        PMID: 21666870      PMCID: PMC3111058          DOI: 10.4081/jnai.2010.e8

Source DB:  PubMed          Journal:  J Nucleic Acids Investig        ISSN: 2036-7996


  48 in total

1.  Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6.

Authors:  S Natsuka; S Akira; Y Nishio; S Hashimoto; T Sugita; H Isshiki; T Kishimoto
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

2.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

3.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

4.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

Review 6.  miR-155: on the crosstalk between inflammation and cancer.

Authors:  Esmerina Tili; Carlo M Croce; Jean-Jacques Michaille
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

Review 7.  Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.

Authors:  Brian J Scaglione; Erica Salerno; Murugabaskar Balan; Frederick Coffman; Pablo Landgraf; Fatima Abbasi; Sergei Kotenko; Gerald E Marti; Elizabeth S Raveche
Journal:  Br J Haematol       Date:  2007-10-17       Impact factor: 6.998

8.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

9.  Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.

Authors:  Ramiro Garzon; Michela Garofalo; Maria Paola Martelli; Roger Briesewitz; Lisheng Wang; Cecilia Fernandez-Cymering; Stefano Volinia; Chang-Gong Liu; Susanne Schnittger; Torsten Haferlach; Arcangelo Liso; Daniela Diverio; Marco Mancini; Giovanna Meloni; Robin Foa; Massimo F Martelli; Cristina Mecucci; Carlo M Croce; Brunangelo Falini
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

10.  The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling.

Authors:  Q Liu; A J Oliveira-Dos-Santos; S Mariathasan; D Bouchard; J Jones; R Sarao; I Kozieradzki; P S Ohashi; J M Penninger; D J Dumont
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  9 in total

Review 1.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

Review 2.  miR deregulation in CLL.

Authors:  Veronica Balatti; Yuri Pekarky; Lara Rizzotto; Carlo M Croce
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

3.  Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.

Authors:  L D'Abundo; E Callegari; A Bresin; A Chillemi; B K Elamin; P Guerriero; X Huang; E Saccenti; E M A A Hussein; F Casciano; P Secchiero; G Zauli; G A Calin; G Russo; L J Lee; C M Croce; G Marcucci; S Sabbioni; F Malavasi; M Negrini
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

4.  Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.

Authors:  Urmila Santanam; Nicola Zanesi; Alexey Efanov; Stefan Costinean; Alexey Palamarchuk; John P Hagan; Stefano Volinia; Hansjuerg Alder; Laura Rassenti; Thomas Kipps; Carlo M Croce; Yuri Pekarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 5.  Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Authors:  Alessandra Drusco; Yuri Pekarsky; Stefan Costinean; Anna Antenucci; Laura Conti; Stefano Volinia; Rami I Aqeilan; Kay Huebner; Nicola Zanesi
Journal:  J Biomed Biotechnol       Date:  2010-12-29

6.  Is miR-29 an oncogene or tumor suppressor in CLL?

Authors:  Yuri Pekarsky; Carlo M Croce
Journal:  Oncotarget       Date:  2010-07

7.  Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth.

Authors:  Z-J Ren; X-Y Nong; Y-R Lv; H-H Sun; P-P An; F Wang; X Li; M Liu; H Tang
Journal:  Cell Death Dis       Date:  2014-08-21       Impact factor: 8.469

8.  Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection.

Authors:  Pauline Floch; Caroline Capdevielle; Cathy Staedel; Julien Izotte; Elodie Sifré; Amandine M Laur; Alban Giese; Victoria Korolik; Pierre Dubus; Francis Mégraud; Philippe Lehours
Journal:  Front Cell Infect Microbiol       Date:  2017-05-16       Impact factor: 5.293

Review 9.  Abnormal microRNA expression in the course of hematological malignancies.

Authors:  Agnieszka Szymczyk; Arkadiusz Macheta; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2018-10-08       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.